A carregar...

Non-cardiac benefits of human recombinant erythropoietin in end stage renal failure and anaemia.

Recombinant human erythropoietin (r-HuEpo) is now available to correct the anaemia of end stage renal failure. The clinical consequences of increasing the haemoglobin concentration in children on dialysis are incompletely documented; a placebo controlled study is essential when assessing subjective...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Morris, K P, Sharp, J, Watson, S, Coulthard, M G
Formato: Artigo
Idioma:Inglês
Publicado em: 1993
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1029623/
https://ncbi.nlm.nih.gov/pubmed/8257180
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!